The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.03 (1.80%)
Spread: 0.20 (12.50%)
Open: 1.67
High: 1.725
Low: 1.67
Prev. Close: 1.67
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Tender Offer and General/Class Meetings

3 Jul 2019 12:21

RNS Number : 3823E
Life Settlement Assets PLC
03 July 2019
 

Life Settlement Assets PLC

LEI: 2138003OL2VBXWG1BZ27

(the "Company" or "LSA")

Results of the Tender Offer

Results of General Meeting and Ordinary Share Class Meetings

 

Life Settlement Assets plc today announces the results of the Tender Offer, the General Meeting and the A Ordinary Share Class Meeting (the "Meetings"), as set out in the circular to Shareholders published by the Company on 4 June 2019 (the "Circular"). The Tender Offer closed at 1.00 p.m. on 1 July 2019.

Result of Tender Offer

The Board announces that a total of 33,474,675 A Ordinary Shares, being 73.7 per cent. of the Company's A Ordinary Shares in issue as at the Record Date, were tendered under the Tender Offer. As a result, the Tender Offer was oversubscribed and in total 5,555,555 A Ordinary Shares were validly tendered under the Tender Offer, including any Ordinary Shares validly tendered in excess of the Basic Entitlement. All A Ordinary Shares validly tendered under the Tender Offer will be satisfied in full. Excess applications have been scaled back and allocated on a pro-rata basis. The A Ordinary Shares repurchased under the Tender Offer will be cancelled.

It is expected that payments will be made in respect of successfully tendered uncertificated A Ordinary Shares through CREST and that, as applicable, cheques will be dispatched in respect of successfully tendered certificated A Ordinary Shares, within five business days or as soon as practicable after 4 July 2019.

In respect of tendered shares not repurchased due to scaling back of Excess Applications, balancing share certificates will be despatched and CREST accounts will be settled within five business days or as soon as practicable after 4 July 2019.

Result of Meetings

The Company is pleased to announce that at the General Meeting and subsequent A Ordinary Share Class Meeting held earlier today, each of the Special Resolutions proposed in the notices of Meetings, required for the implementation of the Tender Offer, were duly passed.

Additionally, the Special Resolution proposed in the notice of Annual General Meeting ("AGM") was passed at the adjourned B Ordinary Share Class Meeting.

Total Voting Rights

Following implementation of the Tender Offer, the Company will have 39,891,391 A Ordinary Shares of $0.01 each, 14,596,098 B Ordinary Shares of $0.01 each, 9,292,561 D Ordinary Shares of $0.01 each and 1,733,269 E Ordinary Shares of $0.01 each. The Company holds no shares in Treasury.

Each Share carries the same voting rights (save in respect of matters relating solely to a specific Share Class) therefore the total number of voting rights in the Company is 65,513,319. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Defined terms used in this announcement have the meanings given in the Circular unless the context otherwise requires.

 

Enquiries:

Acheron Capital Limited (Investment Manager) 

Jean-Michel Paul 

020 7258 5990 

 

Shore Capital (Financial Adviser and Broker) 

Robert Finlay

020 7601 6115 

 

George Bayer / Kerry Higgins 

Maitland Administration Services Limited 

Company Secretary

Tel: 01245 209780 

 

TB Cardew (Financial PR) 

Shan Shan Willenbrock 

020 7930 0777 

 

Notes to Editors

LSA is a closed-ended investment company which manages portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The life settlement market enables individuals to sell their life insurance policies to investors at a higher cash value than they would otherwise receive from insurance companies (if they were cancelled or surrendered at the date of sale). The Company aims to manage portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs. LSA is listed on the Specialist Fund Segment of the Main Market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFXLFBKDFFBBK
Date   Source Headline
1st Mar 20244:13 pmRNSPolicy Maturities
1st Mar 20243:40 pmRNSNet Asset Value(s)
15th Feb 20243:00 pmRNSDividend Declaration
2nd Feb 20244:15 pmRNSNet Asset Value(s)
24th Jan 20249:54 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSPolicy Maturities and update on MBC settlement
13th Dec 202310:35 amRNSHolding(s) in Company
13th Nov 20239:34 amRNSNet Asset Value(s)
17th Oct 20235:14 pmRNSNet Asset Value(s)
27th Sep 20237:00 amRNSHalf-year Report
20th Sep 202311:53 amRNSNet Asset Value(s)
18th Aug 20239:52 amRNSNet Asset Value(s)
17th Jul 20231:06 pmRNSNet Asset Value(s)
14th Jun 20234:14 pmRNSAGM Statement
2nd Jun 202310:17 amRNSNet Asset Value(s)
30th May 202312:33 pmRNSNet Asset Value(s)
16th May 202312:26 pmRNSNet Asset Value(s)
28th Apr 20237:00 amRNSFinal Results
5th Apr 20239:33 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSUpdate on MBC Auction
6th Mar 20233:22 pmRNSHolding(s) in Company
6th Mar 20237:00 amRNSUpdate on MBC Auction
23rd Feb 20233:25 pmRNSNet Asset Value(s)
23rd Feb 20231:56 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDividend Declaration
27th Jan 20234:44 pmRNSUpdate on MBC Auction
16th Jan 202311:40 amRNSNet Asset Value(s)
30th Dec 20227:00 amRNSUpdate on MBC Auction
12th Dec 20227:00 amRNSUpdate on MBC Auction
5th Dec 20222:40 pmRNSStatement re MBC Auction
2nd Dec 20226:21 pmRNSNet Asset Value(s)
14th Nov 202211:24 amRNSNet Asset Value(s)
29th Sep 20223:42 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
8th Sep 20221:32 pmRNSNet Asset Value(s)
10th Aug 202210:09 amRNSNet Asset Value(s)
12th Jul 20225:35 pmRNSHolding(s) in Company
7th Jul 202212:07 pmRNSNet Asset Value(s)
30th Jun 20227:00 amRNSStatement re agreement to reduce performance fee
23rd Jun 20224:22 pmRNSResult of Annual General Meeting
22nd Jun 20224:56 pmRNSNet Asset Value(s)
26th May 202210:56 amRNSNet Asset Value(s)
23rd May 20222:16 pmRNSNet Asset Value(s)
22nd Apr 20227:00 amRNSFinal Results
30th Mar 202210:03 amRNSNet Asset Value(s)
2nd Mar 202211:22 amRNSNet Asset Value(s)
16th Feb 20224:41 pmRNSHolding(s) in Company
19th Jan 20221:05 pmRNSNet Asset Value(s)
21st Dec 202112:08 pmRNSHolding(s) in Company
15th Dec 202110:07 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.